Inhibiting polymerization: New therapeutic strategies for Z α1-antitrypsin-related emphysema

American Journal of Respiratory Cell and Molecular Biology

Volumn 31, Issue 2 I, 2004, Pages 133-139

  Parfrey, Helen ^a   Dafforn, Timothy R ^a   Belorgey, Didier ^a   Lomas, David A ^a   Mahadeva, Ravi ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; PEPTIDE DERIVATIVE; PHENYLALANYLLEUCYLGLUTAMYLALANYLISOLEUCYLGLYCINE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ACETYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; COMPLEX FORMATION; DISSOCIATION; DRUG EFFECT; DRUG MECHANISM; EMPHYSEMA; ENZYME INHIBITION; POLYMERIZATION;

ALPHA 1-ANTITRYPSIN; AMINO ACID SEQUENCE; BIOPOLYMERS; CIRCULAR DICHROISM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EMPHYSEMA; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 4143133190     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0276OC     Document Type: Article

References (35)

1. Silverman, G. A., P. I. Bird, R. W. Carrell, F. C. Church, P. B. Coughlin, P. Gettins, J. Irving, D. A. Lomas, R. W. Moyer, P. Pemberton, E. Remold, S. G. O'Donnell, J. Travis, and J. Whisstock. 2001. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins: evolution, novel functions, mechanism of inhibition and a revised nomenclature. J. Biol. Chem. 276:33293-33296.
2. Wright, H. T., and J. N. Scarsdale. 1995. Structural basis for serpin inhibitor activity. Proteins 22:210-225.
3. 1-proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J. Mol. Biol. 177:531-556.
4. Stratikos, E., and P. G. W. Gettins. 1999. Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70Å and full insertion of the reactive centre loop into β-sheet A. Proc. Natl. Acad. Sci. USA 96:4808-4813.
5. Wilczynska, M., M. Fa, J. Karolin, P.-I. Ohlsson, L. B.-A. Johansson, and T. Ny. 1997. Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nat. Struct. Biol. 4:354-357.
6. Huntington, J. A., R. J. Read, and R. W. Carrell. 2000. Structure of a serpin-protease complex shows inhibition by deformation. Nature 407:923-926.
7. 1-antitrypsin polymers are formed by reactive loop-β-sheet A linkage. J. Biol. Chem. 275:33663-33668.
8. 1-antitrypsin accumulation in the liver. Nature 357:605-607.
9. Davis, R. L., A. E. Shrimpton, P. D. Holohan, C. Bradshaw, D. Feiglin, P. Sonderegger, J. Kinter, L. M. Becker, F. Lacbawan, D. Krasnewich, M. Muenke, D. A. Lawrence, M. S. Yerby, C.-M. Shaw, B. Gooptu, P. R. Elliott, J. T. Finch, R. W. Carrell, and D. A. Lomas. 1999. Familial dementia caused by polymerisation of mutant neuroserpin. Nature 401:376-379.
10. Bruce, D., D. J. Perry, J.-Y. Borg, R. W. Carrell, and M. R. Wardell. 1994. Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen VI (187 Asn→Asp). J. Clin. Invest. 94:2265-2274.
11. 436→Thr) results in nonsubstrate-like behaviour and in polymerization of the molecule. J. Biol. Chem. 268:18088-18094.
12. 1-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc. Natl. Acad. Sci. USA 97:67-72.
13. Lomas, D. A., and R. Mahadeva. 2002. Alpha-1-antitrypsin polymerisation and the serpinopathies: pathobiology and prospects for therapy. J. Clin. Invest. 110:1585-1590.
14. Brantly, M., T. Nukiwa, and R. G. Crystal. 1988. Molecular basis of alpha-1-antitrypsin deficiency. Am. J. Med. 84(Suppl. 6A):13-31.
15. 1- antitrypsin related cirrhosis. J. Biol. Chem. 277:6771-6774.
16. 1- antitrypsin. J. Biol. Chem. 274:9548-9555.
17. 1-antitrypsin deficiency, Acta Med. Scand. 432:1-85. (Suppl.)
18. 1-antitrypsin deficiency variants. J. Biol. Chem. 270:8393-8396.
19. 1-antitrypsin by a peptide sequentially similar to β-strand s4A. Eur. J. Biochem. 194:51-56.
20. Lomas, D. A., D. L. Evans, S. R. Stone, W.-S. W. Chang, and R. W. Carrell. 1993. Effect of the Z mutation on the physical and inhibitory properties of alpha-1-antitrypsin. Biochemistry 32:500-508.
21. Skinner, R., W.-S. W. Chang, L. Jin, X. Pei, J. A. Huntington, J.-P. Abrahams, R. W. Carrell, and D. A. Lomas. 1998. Implications for function and therapy of a 2.9Å structure of binary-complexed antithrombin. J Mol. Biol. 283:9-14.
22. Fitton, H. L., R. N. Pike, R. W. Carrell, and W.-S. W. Chang. 1997. Mechanisms of antithrombin polymerisation and heparin activation probed by insertion of synthetic reactive loop peptides. Biol. Chem. 378:1059-1063.
23. Chang, W.-S. W., M. R. Wardell, D. A. Lomas, and R. W. Carrell. 1996. Probing serpin reactive loop conformations by proteolytic cleavage. Biochem. J. 314:647-653.
24. Beatty, K., J. Bieth, and J. Travis. 1980. Kinetics of association of serine proteinases with native and oxidized α-1-proteinase inhibitor and α-1-antichymotrypsin. J. Biol. Chem. 255:3931-3934.
25. Kezdy, F. J., and E. T. Kaiser. 1970. Principles of active site titration of proteolytic enzymes. Methods Enzymol. 19:3-20.
26. 53→Phe): further evidence for intracellular loop-sheet polymerisation. J. Biol. Chem. 268:15333-15335.
27. Morrison, J. F., and C. T. Walsh. 1988. The behavior and significance of slow-binding enzyme inhibitors. Adv. Enzymol. Relat. Areas Mol. Biol. 61:201-301.
28. Bieth, J. G. 1995. Theoretical and practical aspects of proteinase inhibition kinetics. Methods Enzymol. 248:59-84.
29. Belorgey, D., S. Dirrig, M. Amouric, C. Figarella, and J. G. Bieth. 1996. Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin C and aprotinin. Biochem. J. 313:555-560.
30. Xue, Y., P. Björquist, T. Inghardt, M. Linschoten, D. Musil, L. Sjölin, and J. Deinum. 1998. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide. Structure 6:627-636.
31. Schreuder, H. A., B. de Boer, R. Dijkema, J. Mulders, H. J. M. Theunissen, P. D. J. Grootenhuis, and W. G. J. Hol. 1994. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nat. Struct. Biol. 1:48-54.
32. Carrell, R. W., P. E. Stein, G. Fermi, and M. R. Wardell. 1994. Biological implications of a 3Å structure of dimeric antithrombin. Structure 2:257-270.
33. Zhou, A., R. Faint, P. Charlton, R. W. Carrell, and D. A. Lomas. 2001. . Polymerisation of plasminogen activator inhibitor-1. J. Biol. Chem. 276:9115-9122.
34. Wu, J., M. H. Nantz, and M. A. Zern. 2002. Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front. Biosci. 7:717-725.
35. Pap, E. H., T. B. Dansen, R. van Summeren, and K. W. Wirtz. 2001. Peptide-based targeting of fluorophores to organelles in living cells. Exp. Cell Res. 265:288-293.